Anthem Blue Cross Blue Shield of Georgia prior authorization, page 53

CPT code lookup

Each row is one code from the public prior authorization list. The description is the procedure or service name on that source row. This is not a coverage decision.

Prior authorization codes

Prior authorization codes
CodeDescriptionSource
J7203Injection Factor IX, (antihemophilic factor, recombinant), glycoPEGylated, (Rebinyn), 1 IUStandard Local Prior Authorization Code List, Pg 122 Original policy
J7204Injection, Factor VIII, antihemophilic factor (recombinant), (Esperoct), glycopegylated-exei, per IUStandard Local Prior Authorization Code List, Pg 122 Original policy
J7205Injection, Factor VIII Fc fusion protein (recombinant), per IUStandard Local Prior Authorization Code List, Pg 122 Original policy
J7207Injection, Factor VIII, (antihemophilic factor, recombinant), PEGylated, 1 IUStandard Local Prior Authorization Code List, Pg 123 Original policy
J7208Injection, Factor VIII, (antihemophilic factor, recombinant), PEGylated-aucl, (Jivi), 1 IUStandard Local Prior Authorization Code List, Pg 123 Original policy
J7209Injection, Factor VIII, (antihemophilic factor, recombinant), (Nuwiq), 1 IUStandard Local Prior Authorization Code List, Pg 123 Original policy
J7210Injection, Factor VIII, (antihemophilic factor, recombinant), (Afstyla), 1 IUStandard Local Prior Authorization Code List, Pg 123 Original policy
J7211Injection, Factor VIII, (antihemophilic factor, recombinant), (Kovaltry), 1 IUStandard Local Prior Authorization Code List, Pg 123 Original policy
J7212Factor VIIa (antihemophilic factor, recombinant)- jncw (Sevenfact), 1 mcgStandard Local Prior Authorization Code List, Pg 123 Original policy
J7213Injection, coagulation factor ix (recombinant), ixinity, 1 i.u.Standard Local Prior Authorization Code List, Pg 123 Original policy
J7214Injection, Factor VIII/von Willebrand factor complex, recombinant (Altuviiio), per Factor VIII IUStandard Local Prior Authorization Code List, Pg 123 Original policy
J7311Injection, fluocinolone acetonide, intravitreal implant (Retisert), 0.01 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J7312Injection, dexamethasone, intravitreal implant, 0.1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J7313Injection, fluocinolone acetonide, intravitreal implant (Iluvien), 0.01 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J7314Injection, fluocinolone acetonide, intravitreal implant (Yutiq), 0.01 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J7340Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 mlStandard Local Prior Authorization Code List, Pg 123 Original policy
J7351Injection, bimatoprost, intracameral implant, 1 microgramStandard Local Prior Authorization Code List, Pg 123 Original policy
J7352Afamelanotide implant, 1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J7353Anacaulase-bcdb, 8.8% gel, 1 gmStandard Local Prior Authorization Code List, Pg 123 Original policy
J7354Cantharidin for topical administration, 0.7%, single unit dose applicator (3.2 mg)Standard Local Prior Authorization Code List, Pg 123 Original policy
J7355Injection, travoprost, intracameral implant, 1 mcgStandard Local Prior Authorization Code List, Pg 123 Original policy
J7356Injection, foscarbidopa 0.25 mg/foslevodopa 5 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J7686Treprostinil, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, 1.74 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J7999Compounded drug, not otherwise classifiedStandard Local Prior Authorization Code List, Pg 123 Original policy
J9038Injection, axatilimab-csfr, 0.1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J9202Goserelin acetate implant, per 3.6 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J9210Injection, emapalumab-lzsg, 1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J9217Leuprolide acetate (for depot suspension), 7.5 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J9226Histrelin implant (supprelin LA), 50 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J9256Injection, nipocalimab-aahu, 3 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J9312Injection, rituximab, 10 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J9332Injection, efgartigimod alfa-fcab, 2mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J9333Injection, rozanolixizumab-noli, 1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J9334Injection, efgartigimod alfa, 2 mg and hyaluronidase- qvfcStandard Local Prior Authorization Code List, Pg 123 Original policy
J9376Injection, pozelimab-bbfg, 1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
J9381Injection, teplizumab-mzwv, 5 mcgStandard Local Prior Authorization Code List, Pg 123 Original policy
Q3027Injection, interferon beta-1a, 1 mcg for intramuscular useStandard Local Prior Authorization Code List, Pg 123 Original policy
Q3028Injection, interferon beta-1a, 1 mcg for subcutaneous useStandard Local Prior Authorization Code List, Pg 123 Original policy
Q5098Injection, ustekinumab-srlf (imuldosa), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
Q5099Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
Q5100Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
Q5103Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
Q5104Injection, infliximab-abda, biosimilar, (renflexis), 10 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
Q5121Injection, infliximab-axxq, biosimilar, (AVSOLA), 10 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
Q5123Injection, rituximab-arrx, biosimilar, (riabni), 10 mStandard Local Prior Authorization Code List, Pg 123 Original policy
Q5124Injection, ranibizumab-nuna, biosimilar, (Byooviz), 0.1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
Q5128Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
Q5134Injection, natalizumab-sztn (Tyruko), biosimilar, 1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
Q5137Injection, ustekinumab-auub (Wezlana), biosimilar, SC, 1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy
Q5138Injection, ustekinumab-auub (Wezlana), biosimilar, IV, 1 mgStandard Local Prior Authorization Code List, Pg 123 Original policy

Sources

Disclaimer

The information provided on this page is for general informational purposes only and does not constitute billing, coding, or reimbursement advice. Nothing on this page should be relied upon as a substitute for clinician assessment, professional billing guidance, or as a definitive statement of any payor's billing requirements or policies.

Payor agreements, fee schedules, and billing policies vary and are subject to change. Before submitting any claims related to maternity care services, including claims affected by the 2027 CPT code revisions, please consult the applicable payor agreements, coverage policies, and billing guidelines to confirm current requirements for their specific payor contracts.

Substrate makes no representation or warranty regarding the accuracy, completeness, or timeliness of the payor-specific information presented here. Providers are solely responsible for ensuring that all claims are submitted in accordance with applicable payor requirements, and Substrate assumes no liability for claim denials, underpayments, or other adverse outcomes arising from reliance on this information.